Skip to main content
Top
Published in: Angiogenesis 1/2009

01-03-2009 | Original Paper

Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1

Authors: Sébastien Toffoli, Audrey Roegiers, Olivier Feron, Martine Van Steenbrugge, Noëlle Ninane, Martine Raes, Carine Michiels

Published in: Angiogenesis | Issue 1/2009

Login to get access

Abstract

The presence of hypoxia in tumor and its role in promoting angiogenesis are well-established. Recently, in addition to chronic hypoxia, cycling or intermittent hypoxia has also been demonstrated. However, its role in inducing new blood vessel formation is less clear. This work is aimed to investigate whether intermittent hypoxia can induce a pro-angiogenic phenotype in endothelial cells, in vitro. We studied changes in the expression of genes involved in inflammation and angiogenesis under intermittent and chronic hypoxia. We evidenced genes specifically expressed under intermittent hypoxia, suggesting different cell responses induced by intermittent versus chronic hypoxia. An increase in the expression of pro-angiogenic and pro-inflammatory genes under intermittent hypoxia, translating a pro-angiogenic effect of intermittent hypoxia was detected. In parallel, we investigated the activity of three transcription factors known to be activated either under hypoxia or by reoxygenation: HIF-1, Nrf2, and NF-κB. HIF-1α stabilization and an increase in HIF-1 transcriptional activity were evidenced under intermittent hypoxia. On the other hand, NRF2 and NF-κB transcription factors were not activated. Finally, an increase in endothelial cell migration and in tubulogenesis in the course of hypoxia–reoxygenation cycles was evidenced, which was inhibited by HIF-1α siRNA. All together, these results demonstrate a clear pro-angiogenic effect of intermittent hypoxia.
Literature
1.
go back to reference Morikawa S, Baluk P, Kaidoh T et al (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000PubMed Morikawa S, Baluk P, Kaidoh T et al (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000PubMed
3.
go back to reference Sorg BS, Hardee ME, Agarwal N et al (2008) Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors. J Biomed Opt 13:014026PubMedCrossRef Sorg BS, Hardee ME, Agarwal N et al (2008) Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors. J Biomed Opt 13:014026PubMedCrossRef
4.
go back to reference Toffoli S, Michiels C (2008) Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 275(12):2991–3002PubMedCrossRef Toffoli S, Michiels C (2008) Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 275(12):2991–3002PubMedCrossRef
6.
go back to reference Salceda S, Caro J (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272:22642–22647. doi:10.1074/jbc.272.36.22642 PubMedCrossRef Salceda S, Caro J (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272:22642–22647. doi:10.​1074/​jbc.​272.​36.​22642 PubMedCrossRef
10.
go back to reference Jewell UR, Kvietikova I, Scheid A (2001) Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J 15:1312–1314PubMed Jewell UR, Kvietikova I, Scheid A (2001) Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J 15:1312–1314PubMed
11.
go back to reference Jiang BH, Rue E, Wang GL et al (1996) Dimerization, DNA binding, transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271:17771–17778PubMedCrossRef Jiang BH, Rue E, Wang GL et al (1996) Dimerization, DNA binding, transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271:17771–17778PubMedCrossRef
12.
go back to reference Wenger RH (2000) Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 203:1253–1263PubMed Wenger RH (2000) Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 203:1253–1263PubMed
14.
go back to reference Poli G, Leonarduzzi G, Biasi F et al (2004) Oxidative stress and cell signalling. Curr Med Chem 11:1163–1182PubMed Poli G, Leonarduzzi G, Biasi F et al (2004) Oxidative stress and cell signalling. Curr Med Chem 11:1163–1182PubMed
25.
go back to reference Wang XJ, Sun Z, Villeneuve NF et al (2008) Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235–1243PubMedCrossRef Wang XJ, Sun Z, Villeneuve NF et al (2008) Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235–1243PubMedCrossRef
28.
go back to reference Wellington CL, Ellerby LM, Hackam AS et al (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158–9167. doi:10.1074/jbc.273.15.9158 PubMedCrossRef Wellington CL, Ellerby LM, Hackam AS et al (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158–9167. doi:10.​1074/​jbc.​273.​15.​9158 PubMedCrossRef
30.
go back to reference Remacle JA, Houbion A, Houben A (1980) Subcellular fractionation of WI-38 fibroblasts. Comparison between young and old cells. Biochim Biophys Acta 630:57–70PubMed Remacle JA, Houbion A, Houben A (1980) Subcellular fractionation of WI-38 fibroblasts. Comparison between young and old cells. Biochim Biophys Acta 630:57–70PubMed
31.
go back to reference Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275. doi:10.1038/20459 PubMedCrossRef Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275. doi:10.​1038/​20459 PubMedCrossRef
32.
go back to reference Leonard MO, Kieran NE, Howell K et al (2006) Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 20:2624–2626. doi:10.1096/fj.06-5097fje PubMedCrossRef Leonard MO, Kieran NE, Howell K et al (2006) Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 20:2624–2626. doi:10.​1096/​fj.​06-5097fje PubMedCrossRef
33.
go back to reference de Longueville F, Atienzar FA, Marcq L et al (2003) Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol Sci 75:378–392. doi:10.1093/toxsci/kfg196 PubMedCrossRef de Longueville F, Atienzar FA, Marcq L et al (2003) Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol Sci 75:378–392. doi:10.​1093/​toxsci/​kfg196 PubMedCrossRef
35.
go back to reference Debacq-Chainiaux F, Borlon C, Pascal T et al (2005) Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-beta1 signaling pathway. J Cell Sci 118:743–758. doi:10.1242/jcs.01651 PubMedCrossRef Debacq-Chainiaux F, Borlon C, Pascal T et al (2005) Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-beta1 signaling pathway. J Cell Sci 118:743–758. doi:10.​1242/​jcs.​01651 PubMedCrossRef
37.
go back to reference Toffoli S, Feron O, Raes M et al (2007) Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKA-dependent regulation of HIF-1alpha. Biochim Biophys Acta 1773:1558–1571PubMedCrossRef Toffoli S, Feron O, Raes M et al (2007) Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKA-dependent regulation of HIF-1alpha. Biochim Biophys Acta 1773:1558–1571PubMedCrossRef
40.
go back to reference Wang YD, Hu Y, Sun CY et al (2006) Involvement of AKT/eNOS in brain derived neurotrophic factor-induced angiogenesis. Zhonghua Xue Ye Xue Za Zhi 27:529–533PubMed Wang YD, Hu Y, Sun CY et al (2006) Involvement of AKT/eNOS in brain derived neurotrophic factor-induced angiogenesis. Zhonghua Xue Ye Xue Za Zhi 27:529–533PubMed
43.
go back to reference Compagni A, Wilgenbus P, Impagnatiello MA et al (2000) Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 60:7163–7169PubMed Compagni A, Wilgenbus P, Impagnatiello MA et al (2000) Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 60:7163–7169PubMed
44.
go back to reference Lacaud G, Gore L, Kennedy M et al (2002) Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 100:458–466PubMedCrossRef Lacaud G, Gore L, Kennedy M et al (2002) Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 100:458–466PubMedCrossRef
46.
go back to reference Iwatsuki K, Tanaka K, Kaneko T et al (2005) Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3. Oncogene 24:1129–1137PubMedCrossRef Iwatsuki K, Tanaka K, Kaneko T et al (2005) Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3. Oncogene 24:1129–1137PubMedCrossRef
53.
go back to reference Patey N, Vazeux R, Canioni D et al (1996) Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses. Am J Pathol 148:465–472PubMed Patey N, Vazeux R, Canioni D et al (1996) Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses. Am J Pathol 148:465–472PubMed
Metadata
Title
Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1
Authors
Sébastien Toffoli
Audrey Roegiers
Olivier Feron
Martine Van Steenbrugge
Noëlle Ninane
Martine Raes
Carine Michiels
Publication date
01-03-2009
Publisher
Springer Netherlands
Published in
Angiogenesis / Issue 1/2009
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-009-9131-y

Other articles of this Issue 1/2009

Angiogenesis 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.